<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28978801</article-id>
<article-id pub-id-type="pmc">5841876</article-id>
<article-id pub-id-type="publisher-id">95302</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.95302</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Medicine</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bhargava</surname>
<given-names>Pavan</given-names>
</name>
<email>pbharga2@jhmi.edu</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fitzgerald</surname>
<given-names>Kathryn C.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Calabresi</surname>
<given-names>Peter A.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mowry</surname>
<given-names>Ellen M.</given-names>
</name>
</contrib>
</contrib-group>
<aff>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Pavan Bhargava, 600 N. Wolfe Street, Pathology 627, Baltimore, Maryland 21287, USA. Phone: 410.614.1522; Email: <email>pbharga2@jhmi.edu</email>.</corresp>
<fn>
<p><bold>Authorship note:</bold> P. Bhargava and K.C. Fitzgerald contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> P.A. Calabresi reports grants from MedImmune, grants from Biogen, grants from Novartis, grants from Teva, personal fees from Biogen, and personal fees from Vertex outside the submitted work. E.M. Mowry reports grants from Biogen, other support from UpToDate, nonfinancial support from Teva, other support from Sun Pharma, other support from Biogen, and grants from Sanofi Genzyme outside the submitted work.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2017-10-05T09:00:00-0400" publication-format="electronic">
<day>5</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2017-10-05T09:00:00-0400" publication-format="electronic">
<day>5</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>5</day>
<month>10</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>2</volume>
<issue>19</issue>
<elocation-id>e95302</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/95302">This article is available online at https://insight.jci.org/articles/view/95302</self-uri>
<abstract>
<p><bold>BACKGROUND.</bold> Our goal was to identify changes in the metabolome in multiple sclerosis (MS) and how vitamin D supplementation alters metabolic profiles in MS patients and healthy controls.</p>
<p><bold>METHODS.</bold> We applied global untargeted metabolomics to plasma from a cross-sectional cohort of age- and sex-matched MS patients and controls and a second longitudinal cohort of MS patients and healthy controls who received 5,000 IU cholecalciferol daily for 90 days. We applied partial least squares discriminant analysis, weighted correlation network analysis (WGCNA), and pathway analysis to the metabolomics data. Generalized estimating equations models were used to assess change in WGCNA-identified module scores or metabolite pathways with vitamin D supplementation.</p>
<p><bold>RESULTS.</bold> Utilizing multiple analytical techniques, we identified metabolic alterations in oxidative stress (γ-glutamyl amino acid, glutathione) and xenobiotic metabolism (benzoate, caffeine) in MS patients compared with healthy controls in the first cohort. In the vitamin D supplementation cohort, we identified two sets of metabolites altered differentially between MS patients and healthy controls with vitamin D supplementation. The first included markers of oxidative stress and protein oxidation (<italic><italic>P</italic></italic> = 0.006), while the second contained lysolipids and fatty acids (<italic><italic>P</italic></italic> = 0.03).</p>
<p><bold>CONCLUSIONS.</bold> Using metabolomics, we identified alterations in oxidative stress and xenobiotic metabolism in MS patients and subsequently demonstrated a reduction of oxidative stress markers with vitamin D supplementation in healthy controls but not in MS patients. We demonstrate the utility of metabolomics in identifying aberrant metabolic processes and in monitoring the ability of therapeutic interventions to correct these abnormalities.</p>
<p><bold>TRIAL REGISTRATION.</bold> ClinicalTrials.gov NCT01667796.</p>
<p><bold>FUNDING.</bold> This study was supported by NIH grant K23 NS067055, grants from the Race to Erase MS, the National Multiple Sclerosis Society, the American Academy of Neurology, and North American Research Committee on Multiple Sclerosis.</p>
</abstract>
<abstract abstract-type="toc">
<p>Multiple sclerosis patients exhibit alterations in oxidative stress and xenobiotic metabolism, and have unique metabolome changes in response to vitamin D supplementation.</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Immunology</kwd>
<kwd>Neuroscience</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Multiple sclerosis</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Multiple Sclerosis Society</institution>
<institution-id>https://doi.org/10.13039/100000890</institution-id>
</institution-wrap>
</funding-source>
<award-id>Career Transition Award</award-id>
</award-group>
<award-group>
<funding-source>Race to Erase MS</funding-source>
<award-id>Young Investigator Award</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>American Academy of Neurology</institution>
<institution-id>https://doi.org/10.13039/100005339</institution-id>
</institution-wrap>
</funding-source>
<award-id>John F. Kurtzke Clinician Scientist Development Award</award-id>
</award-group>
<award-group>
<funding-source>Race to Erase MS</funding-source>
<award-id>Pilot Award</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Institutes of Health</institution>
<institution-id>https://doi.org/10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>NIH K23 NS067055</award-id>
</award-group>
<award-group>
<funding-source>NARCOMS</funding-source>
<award-id>Post doctoral fellowship</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>